Trombolysebehandling er effektiv højst tre timer efter iskæmisk apopleksi

Ugeskrift for Laeger

Volumn 161, Issue 11, 1999, Pages 1573-1576

  Overgaard, Karsten ^b   Boysen, Gudrun ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO;

CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; PLASMINOGEN ACTIVATION; REVIEW; STROKE; THROMBOSIS PREVENTION; TREATMENT OUTCOME; ACUTE DISEASE; EMERGENCY; RANDOMIZED CONTROLLED TRIAL; TIME;

ACUTE DISEASE; CEREBROVASCULAR DISORDERS; EMERGENCIES; HUMANS; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0033558530     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91: 311-21.
2. Dalal PM, Shah PM, Sheth SC, Deshpande CK. Cerebral embolism. Angiographic observations on spontaneous clot lysis. Lancet 1965; 1; 61-4.
3. Jorgensen HS, Sperling B, Nakayama H, Raaschou HO, Olsen TS. Spontaneous reperfusion of cerebral infarcts in patients with acute stroke. Arch Neurol 1994; 51: 865-73.
4. Baird AE, Austin MC, McKay WJ, Donnan GA. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. J Neurol Neurosurg Psychiatry 1996; 61: 26-9.
5. Sussman BJ, Fitch TSP. Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958; 167: 1705-9.
6. Overgaard K, Sereghy T, Pedersen H, Boysen G. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 1994; 14: 472-7.
7. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-82.
8. Yamaguchi T, Hayakawa T, Kiuchi H. Intravenous tissue plasininogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 1993; 3: 269-72.
9. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997; 350: 607-14.
10. Wardlaw JM, Dorman PJ. Thrombolysis in acute ischaemic stroke. Neurol Rev Int 1996; 1: 2-6.
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-51.
12. Clark WM, Albers GW. The ATLANTIS rt-PA (Alteplase) acute stroke trial: final results. [abstract]. Stroke 1999; 30: 234.
13. Furlan AJ, Higashida R, Wechsler L, Schulz G. PROACT II: recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism. Initial trial results. The PROACT II Investigators [abstract]. Stroke 1999; 30: 234.
14. Tissue plasminogen activator for acute ischemic stroke. The NINDS rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-7.
15. Marier JR, Tilley BC, Lu M, Brott T, Lyrlen P, Broderick JP et al. Earlier treatment associated with better outcome in the NINDS TPA stroke study [abstract]. Stroke 1999; 30: 244.
16. Johnsen SP, Husted SE. Rejsebrev fra 23rd international joint conference on stroke and cerebral circulation. Ugeskr Læger 1998; 160: 4662-3.
17. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997; 28: 2119-25.
18. von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997; 205: 327-33.
19. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28: 2109-18.
20. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
21. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296: 320-31.
22. Viste KM. rt-PA approved for stroke [abstract]. W Neurol 1996; 11: 10.
23. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke 1997; 28: 1530-40.
24. Albers GW. Prospective, monitored, multicenter, post-approval experience with intravenous t-PA for treatment of acute stroke: the standard tratment with activase to reverse stroke (STARS) study [abstract]. Stroke 1999; 30: 244.
25. Kanter DS, Kothari R, Pancioli A, Jauch E, Brott T, Gebel J et al. The greater Cincinnati T-PA experience after the NINDS trial: does a longer time to treatment within the current three-hour window reduce efficacy? [abstract]. Stroke 1999; 30: 244.
26. Grond M, Stenzel C, Schmulling S. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998; 29: 1544-9.
27. Katzan IL, Furlan AJ, Way LE, Frank JI, Harper DL, Hinchey JA et al. A systematic audit of iv tPA use in Cleveland area hospitals [abstract]. Stroke 1999; 30: 266.
28. Behrens S, Interthal C, Luiz T, Koch C, Ellinger K, Hennerici M et al. Shortening of pre-and in-hospital therapeutic delays in acute stroke [abstract]. Stroke 1999; 30: 263.
29. Overgaard K, Sperling B, Boysen G, Pedersen H, Gam J, Ellemann K et al. Thrombolytic therapy in acute ischemic stroke: a Danish pilot study. Stroke 1993; 24: 1439-46.
30. von Kummer R, Del Zoppo GJ, Krölich E, John C, Hacke W. Thrombolysis reduces the volume of ischemic lesions in humans [abstract]. Stroke 1996; 27: 164.